Add-on Acquisition • Life Science

Piramal Enterprises Acquires Coldstream Laboratories

On January 16, 2015, Piramal Enterprises acquired life science company Coldstream Laboratories for 31M USD

Acquisition Context
  • This is Piramal Enterprises’ 4th transaction in the Life Science sector.
  • This is Piramal Enterprises’ 4th largest (disclosed) transaction.
  • This is Piramal Enterprises’ 4th transaction in the United States.
  • This is Piramal Enterprises’ 1st transaction in Kentucky.

Explore All 3116 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date January 16, 2015
Target Coldstream Laboratories
Sector Life Science
Buyer(s) Piramal Enterprises
Deal Type Add-on Acquisition
Deal Value 31M USD

Target Company

Coldstream Laboratories

Lexington, Kentucky, United States
Coldstream Laboratories, Inc. is a specialty pharmaceutical contract manufacturer with an emphasis on clinical trial to commercial-scale manufacturing of sterile liquid and lyophilized parenterals and injectables.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Piramal Enterprises

Mumbai, India

Category Company
Founded 1947
Sector Healthcare Services
Employees16,035
Revenue 89.2B INR (2025)
DESCRIPTION

Piramal Enterprises is a diversified Indian conglomerate. Piramal Group operates healthcare, drug discovery and research, glass, real estate and financial services. Piramal Enterprises was founded in 1947 and is based in Mumbai, Maharashtra.


Deal Context for Buyer #
Overall 9 of 12
Sector: Life Science 4 of 6
Type: Add-on Acquisition 4 of 6
State: Kentucky 1 of 1
Country: United States 4 of 5
Year: 2015 1 of 1
Size (of disclosed) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-12-15 Shriram Capital

Chennai, India

Shriram Capital is the overarching holding company for the Financial Services and Insurance entities of the Shriram Group, created with the primary objective of optimizing the synergies across the Group’s entities. Shriram Capital was founded in 1974 and is based in Chennai, India.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 Piramal Clinical Research

India

Piramal Clinical Research specializes in conducting bioequivalence and bioanalytical studies for generic products.

Sell -